TONIX PHARMACEUTICALS HOLDIN(NASDAQ:TNXP) stock News

TNXP Latest News, Press Relases and Analysis

All

Press Releases

9 hours ago - By: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Announces the Launch of the “Move Fibro Forward” Campaign to Bring Awareness to Individuals Impacted by Fibromyalgia

11 days ago - By: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Announces Presentation of New Data on Mpox and Smallpox Vaccine Candidate TNX-801 at the Vaccine Congress 2025

12 days ago - By: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Announces On-line Publication of Phase 3 RESILIENT Trial Results of TNX-102 SL for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine

14 days ago - By: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Announces Oral Presentation on Mpox and Smallpox vaccine candidate TNX-801 at the Vaccine Congress 2025

19 days ago - By: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in Cancer Cell Journal Highlighting Positive Preclinical Data of mTNX-1700 in Gastric Cancer Animal Models

4 months ago - By: Benzinga

Peering Into Tonix Pharmaceuticals's Recent Short Interest

4 months ago - By: Benzinga - Mentions: ARQT

Top 2 Health Care Stocks That Are Ticking Portfolio Bombs

21 days ago - By: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

a month ago - By: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors

2 months ago - By: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2025

2 months ago - By: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Announces Presentation at the A.G.P. Annual Healthcare Company Showcase

2 months ago - By: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 OASIS Study of TNX-102 SL for Reduction of Acute Stress Reaction

2 months ago - By: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights

3 months ago - By: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting

3 months ago - By: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025

3 months ago - By: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025

3 months ago - By: Yahoo Finance

Why Tonix Pharmaceuticals Corp. (TNXP) Went Down On Thursday?

3 months ago - By: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix’s Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana’s Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies

4 months ago - By: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

4 months ago - By: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference

4 months ago - By: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition

4 months ago - By: ACCESS Newswire

Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year

4 months ago - By: ACCESS Newswire - Mentions: SGTM BIVI RDZN

New to The Street Show #639 Premieres Nationwide on Bloomberg Television, March 29 at 6:30 PM EST Featuring BioVie, Roadzen, Tonix Pharma, and eXoZymes Inc.

4 months ago - By: MarketBeat - Mentions: LXEO

TONIX PHARMACEUTICALS HOLDIN (TNXP) Stock News

TNXP Latest News, Press Relases and Analysis

Tonix Pharmaceuticals Announces the Launch of the “Move Fibro Forward” Campaign to Bring Awareness to Individuals Impacted by Fibromyalgia

Tonix Pharmaceuticals Announces Presentation of New Data on Mpox and Smallpox Vaccine Candidate TNX-801 at the Vaccine Congress 2025

Tonix Pharmaceuticals Announces On-line Publication of Phase 3 RESILIENT Trial Results of TNX-102 SL for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine

Tonix Pharmaceuticals Announces Oral Presentation on Mpox and Smallpox vaccine candidate TNX-801 at the Vaccine Congress 2025

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in Cancer Cell Journal Highlighting Positive Preclinical Data of mTNX-1700 in Gastric Cancer Animal Models

Peering Into Tonix Pharmaceuticals's Recent Short Interest

Top 2 Health Care Stocks That Are Ticking Portfolio Bombs

Tonix Pharmaceuticals Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors

Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2025

Tonix Pharmaceuticals Announces Presentation at the A.G.P. Annual Healthcare Company Showcase

Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 OASIS Study of TNX-102 SL for Reduction of Acute Stress Reaction

Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights

Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025

Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025

Why Tonix Pharmaceuticals Corp. (TNXP) Went Down On Thursday?

Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix’s Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana’s Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference

Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition

Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year

New to The Street Show #639 Premieres Nationwide on Bloomberg Television, March 29 at 6:30 PM EST Featuring BioVie, Roadzen, Tonix Pharma, and eXoZymes Inc.

Pharma Frenzy: Volatility Ignites Biotech Sector